The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study

por Wolfe, Frederick, Michaud, Kaleb
Publicado 2010

A Mobile App With Optical Imaging for the Self-Management of Hand Rheumatoid Arthritis: Pilot Study

por Mollard, Elizabeth, Michaud, Kaleb
Publicado 2018

Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases

por Gabriel, Sherine E, Michaud, Kaleb
Publicado 2009

Using technology to support clinical care and research in rheumatoid arthritis

por Dixon, William G., Michaud, Kaleb
Publicado 2018

Probiotic Use and Psoriatic Arthritis Disease Activity

por Grinnell, Madison, Ogdie, Alexis, Wipfler, Kristin, Michaud, Kaleb
Publicado 2020

Smartphone-based behavioral monitoring and patient-reported outcomes in adults with rheumatic and musculoskeletal disease

por Mollard, Elizabeth, Pedro, Sofia, Schumacher, Rebecca, Michaud, Kaleb
Publicado 2022

The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis

por Hernández Alava, Mónica, Wailoo, Allan, Wolfe, Fred, Michaud, Kaleb
Publicado 2013

Estimation of Minimally Important Differences and Patient Acceptable Symptom State Scores for the Patient‐Reported Outcomes Measurement Information System Pain Interference Short F...

por Katz, Patricia, Kannowski, Carol L., Sun, Luna, Michaud, Kaleb
Publicado 2020

Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects

por Smith, Christopher J, Sayles, Harlan, Mikuls, Ted R, Michaud, Kaleb
Publicado 2011

The Impact of Asthma and Chronic Obstructive Pulmonary Disease (COPD) on Patient‐Reported Outcomes in Systemic Lupus Erythematosus (SLE)

por Katz, Patricia, Pedro, Sofia, Trupin, Laura, Yelin, Edward, Michaud, Kaleb
Publicado 2021

Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?

por Ozen, Gulsen, Pedro, Sofia, Schumacher, Rebecca, Simon, Teresa, Michaud, Kaleb
Publicado 2021

The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis

por Shafrin, Jason, Tebeka, Mahlet Gizaw, Price, Kwanza, Patel, Chad, Michaud, Kaleb
Publicado 2018

Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational...

por Ozen, Gulsen, Pedro, Sofia, Schumacher, Rebecca, Simon, Teresa A., Michaud, Kaleb
Publicado 2019

Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis

por Ogdie, Alexis, Maksabedian Hernandez, Ervant J., Shaw, Yomei, Stolshek, Bradley, Michaud, Kaleb
Publicado 2022

Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs

por Ozen, Gulsen, Pedro, Sofia, England, Bryant R., Mehta, Bella, Wolfe, Frederick, Michaud, Kaleb
Publicado 2019

Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study

por Ogdie, Alexis, Shaw, Yomei, Almonte, Michele, Maksabedian Hernandez, Ervant J., Stolshek, Bradley, Michaud, Kaleb
Publicado 2023

Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty

por Michaud, Kaleb, Fehringer, Edward V, Garvin, Kevin, O’Dell, James R, Mikuls, Ted R
Publicado 2013

Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?

por Ramiro, Sofia, Landewé, Robert, van der Heijde, Désirée, Harrison, David, Collier, David, Michaud, Kaleb
Publicado 2015

Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively...

por Fournier, Marie, Chen, Chieh-I, Kuznik, Andreas, Proudfoot, Clare, Mallya, Usha G, Michaud, Kaleb
Publicado 2019

Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study

por Mehta, Bella, Pedro, Sofia, Ozen, Gulsen, Kalil, Andre, Wolfe, Frederick, Mikuls, Ted, Michaud, Kaleb
Publicado 2019